Company Filing History:
Years Active: 2016-2019
Title: Barbara Ann Williams: Innovator in Pharmaceutical Formulations
Introduction
Barbara Ann Williams is a notable inventor based in Indianapolis, IN (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of anti-IL-17 antibody treatments. With a total of 3 patents to her name, her work has the potential to impact the treatment of various autoimmune diseases.
Latest Patents
Her latest patents include innovative formulations for anti-IL-17 antibodies. The first patent provides pharmaceutical formulations that can be used to treat conditions such as rheumatoid arthritis, psoriasis, ankylosing spondylitis, psoriatic arthritis, and multiple myeloma. The second patent focuses on stabilized pharmaceutical formulations for anti-IL-17 antibodies, which include components like citrate, sodium chloride, and polysorbate-80 at a pH of 5.7. These formulations are designed to enhance the efficacy of treatments for the aforementioned diseases.
Career Highlights
Barbara Ann Williams is currently associated with Eli Lilly and Company, where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to improving patient outcomes through advanced therapeutic solutions.
Collaborations
She has collaborated with notable colleagues such as Vincent John Corvari and Patrick Daniel Donovan, contributing to a dynamic research environment that fosters innovation.
Conclusion
Barbara Ann Williams stands out as a pioneering inventor in the pharmaceutical industry, with her work on anti-IL-17 antibody formulations paving the way for new treatment options. Her contributions are vital in addressing complex health challenges faced by patients today.